Cargando…

Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients

Combined antiretroviral therapy (cART) is treatment with a combination of several antiretroviral drugs that block multiple stages in the virus replication cycle. An estimated 60% of the 38 million HIV-1 patients globally receive some form of cART. The benefits of cART for controlling HIV-1 replicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weichseldorfer, Matthew, Reitz, Marvin, Latinovic, Olga S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621549/ https://www.ncbi.nlm.nih.gov/pubmed/34834213 http://dx.doi.org/10.3390/pharmaceutics13111798

Ejemplares similares

Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence
por: Weichseldorfer, Matthew, et al.
Publicado: (2020)

Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies
por: Weichseldorfer, Matthew, et al.
Publicado: (2022)

CCR5 Inhibitors and HIV-1 Infection
por: Latinovic, Olga S., et al.
Publicado: (2019)

Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice
por: Weichseldorfer, Matthew, et al.
Publicado: (2021)

Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy
por: Bhatti, Adnan Bashir, et al.
Publicado: (2016)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
por: Iyidogan, Pinar, et al.
Publicado: (2014)

A novel small-molecule inhibitor of HIV-1 entry
por: Heredia, Alonso, et al.
Publicado: (2015)

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
por: Destache, Christopher J, et al.
Publicado: (2009)

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
por: Harris, Marianne, et al.
Publicado: (2012)

Change in Nutritional and Biochemical Status in People Living with HIV-1 on Antiretroviral Therapy
por: de Souza, Ranilda Gama, et al.
Publicado: (2022)

Current Status of HIV-1 Vaccines
por: Hargrave, Anna, et al.
Publicado: (2021)

The HIV-1 Transgenic Rat: Relevance for HIV Noninfectious Comorbidity Research
por: Denaro, Frank, et al.
Publicado: (2020)

Antiretroviral Drug Discovery Targeting the HIV-1 Nef Virulence Factor
por: Emert-Sedlak, Lori A., et al.
Publicado: (2022)

Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008)

Past and current status of adolescents living with HIV in South Africa, 2005–2017
por: Inbarani, Naidoo, et al.
Publicado: (2022)

Neurologic Abnormalities in HIV-1 Infected Children in the Era of Combination Antiretroviral Therapy
por: van Arnhem, Lotus A., et al.
Publicado: (2013)

Tolerability of four‐drug antiretroviral combination therapy in primary HIV‐1 infection
por: Burns, JE, et al.
Publicado: (2021)

Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants
por: McManus, Margaret, et al.
Publicado: (2016)

Progressive HIV-associated Cholangiopathy in an HIV Patient Treated with Combination Antiretroviral Therapy
por: Imai, Kazuo, et al.
Publicado: (2016)

HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples
por: Lihana, Raphael W, et al.
Publicado: (2009)

1493. Effect of HIV Status on Early Syphilis Treatment Response in the Era of Combination Antiretroviral Therapy
por: King, Helen, et al.
Publicado: (2018)

Persistent HIV-1 replication during antiretroviral therapy
por: Martinez-Picado, Javier, et al.
Publicado: (2016)

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy
por: Prins, Henrieke A. B., et al.
Publicado: (2023)

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults
por: DeJesus, Edwin, et al.
Publicado: (2019)

HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women
por: Kovacs, Laszlo, et al.
Publicado: (2022)

HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy
por: Castelli, Roberto, et al.
Publicado: (2020)

Norovirus infection among HIV-infected patients in Abuja, Nigeria: impact of combination antiretroviral therapy status
por: Osazuwa, Favour, et al.
Publicado: (2023)

Antiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts
por: Granich, Reuben, et al.
Publicado: (2011)

HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy
por: Morris, Lynn, et al.
Publicado: (1998)

Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects
por: Li, Yijia, et al.
Publicado: (2016)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
por: Castro, Hannah, et al.
Publicado: (2012)

Antiretroviral medication adherence for people with HIV/AIDS
por: Supriyatni, Nani, et al.
Publicado: (2023)

A Quantitative Basis for Antiretroviral Therapy for HIV-1 Infection
por: Jilek, Benjamin L., et al.
Publicado: (2012)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy
por: Kemp, Steven A., et al.
Publicado: (2022)

Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration
por: Boufassa, Faroudy, et al.
Publicado: (2014)

HIV Status Disclosure and Retention in Care in HIV-Infected Adolescents on Antiretroviral Therapy (ART) in West Africa
por: Arrivé, Elise, et al.
Publicado: (2012)

Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV
por: Barthold, Douglas, et al.
Publicado: (2023)

2516. Persistence of Anti-HIV Antibodies in HIV-1-infected Patients on Combination Antiretroviral Therapy (cART) with Prolonged Viral Suppression
por: Singh, Kanal, et al.
Publicado: (2019)

Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children
por: Kuhn, Louise, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qguer4ckjgaj10574no85vh9f8